文献速递帕金森病与运动障碍

帕金森病患者八小时自适应脑深部电刺激研究

Eight-hours adaptive deep brain stimulation in patients with Parkinson disease.
PubMed 文献 · Neurology · 2018-02-14

本研究为开放标签、非盲法研究,评估基于局部场电位(LFP)的自适应脑深部电刺激(aDBS)在晚期帕金森病患者日常活动中的可行性与临床疗效。在两次长达8小时的围手术期实验 sessions 中监测神经生理与临床波动,结果显示 beta 频段功率与患者临床状态相关(r=0.506,p<0.001;r=0.477,p<0.001),aDBS 有效(未用药时改善30%,3因素方差分析交互作用 p=0.036;30.5±3.4 vs 22.2±3.3,p=0.003)、安全且耐受良好,并能减少运动“开”期 DBS 幅度(配对 t 检验 p=0.046),防止异动症。结论认为 aDBS 在日常生活中的技术可行,为临床波动管理提供安全、耐受良好且有效的治疗方法。证据等级为 IV 级。

要点

  • beta 频段功率与患者临床状态相关(r=0.506,p<0.001;r=0.477,p<0.001)。
  • aDBS 有效:未用药时改善30%(30.5±3.4 vs 22.2±3.3,p=0.003)。
  • aDBS 安全、耐受良好,可减少运动“开”期 DBS 幅度(配对 t 检验 p=0.046)并防止异动症。

核心结论

  • aDBS 在日常生活中的技术可行,为临床波动管理提供安全、耐受良好且有效的治疗方法。
  • 证据等级为 IV 级,表明对晚期帕金森病患者,aDBS 在控制运动症状方面安全、耐受良好且有效。

研究设计与样本

  • 开放标签、非盲法研究,纳入晚期帕金森病患者,监测两次围手术期实验 sessions(每次长达8小时)的神经生理与临床波动。
  • 第一天患者服用日常药物,第二天额外接受由 LFP beta 频段功率驱动的丘脑底核 aDBS。

主要发现

  • beta 频段功率在两次实验 sessions 中均与患者临床状态相关(Pearson 相关系数 r=0.506,p<0.001;r=0.477,p<0.001)。
  • aDBS 在未用药时有效(改善30%;3因素方差分析交互作用 day × medication p=0.036;30.5±3.4 vs 22.2±3.3,p=0.003),安全且耐受良好。
  • aDBS 在运动“开”状态较“关”状态降低 DBS 幅度(配对 t 检验 p=0.046),该自动调整防止了异动症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the feasibility and clinical efficacy of local field potentials (LFPs)-based adaptive deep brain stimulation (aDBS) in patients with advanced Parkinson disease (PD) during daily activities in an open-label, nonblinded study. METHODS: We monitored neurophysiologic and clinical fluctuations during 2 perioperative experimental sessions lasting for up to 8 hours. On the first day, the patient took his/her daily medication, while on the second, he/she additionally underwent subthalamic nucleus aDBS driven by LFPs beta band power. RESULTS: The beta band power correlated in both experimental sessions with the patient's clinical state (Pearson correlation coefficient r = 0.506, p < 0.001, and r = 0.477, p < 0.001). aDBS after LFP changes was effective (30% improvement without medication [3-way analysis of variance, interaction day × medication p = 0.036; 30.5 ± 3.4 vs 22.2 ± 3.3, p = 0.003]), safe, and well tolerated in patients performing regular daily activities and taking additional dopaminergic medication. aDBS was able to decrease DBS amplitude during motor "on" states compared to "off" states (paired t test p = 0.046), and this automatic adjustment of STN-DBS prevented dyskinesias. CONCLUSIONS: The main findings of our study are that aDBS is technically feasible in everyday life and provides a safe, well-tolerated, and effective treatment method for the management of clinical fluctuations. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for patients with advanced PD, aDBS is safe, well tolerated, and effective in controlling PD motor symptoms.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Arlotti M, Marceglia S, Foffani G, et al. Eight-hours adaptive deep brain stimulation in patients with Parkinson disease. Neurology. 2018. PMID: 29444973. doi:10.1212/WNL.0000000000005121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。